Gliclazide

규격

21187-98-4CAS 번호

244-260-5EC 번호

1-(3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl)-3-(4-methylphenyl)sulfonylureaIUPAC 명칭

C15H21N3O3S화학식

323.4 g/mol분자량

gliclazide; 21187-98-4; Glimicron; Diamicron; Gliclazida; DTXSID9023095; S-852; S-1702; 1-(3-Azabicyclo(3.3.0)oct-3-yl)-3-(p-tolylsulfonyl)urea; 1-(Hexahydrocyclopenta(c)pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)urea; CHEBI:31654; NSC-758673; J3.151H; SE-1702; Gliclazidum; SE 1702; DTXCID003095; Glyclazide; Gliklazid; S 1702; 1-(Hexahydrocyclopenta[c]pyrrol-2(1H)-yl)-3-[(4-methylphenyl)sulfonyl]urea; S 852; Benzenesulfonamide, N-(((hexahydrocyclopenta(c)pyrrol-2(1H)-yl)amino)carbonyl)-4-methyl-; Benzenesulfonamide, N-[[(hexahydrocyclopenta[c]pyrrol-2(1H)-yl)amino]carbonyl]-4-methyl-; Gen Gliclazide; Novo Gliclazide; Diamicron MR; 1-[(4-methylbenzene)sulfonyl]-3-{octahydrocyclopenta[c]pyrrol-2-yl}urea; Bilxona; Ziclaseg; Edicil; Glimil; Zicron; Vamju; Dacadis mr; Nazdol mr; Vitile xl; Zicron pr; 1-((4-methylbenzene)sulfonyl)-3-(octahydrocyclopenta(c)pyrrol-2-yl)urea; 1-(Hexahydrocyclopenta(c)pyrrol-2(1H)-yl)-3-((4-methylphenyl)sulfonyl)urea; S852; RefChem:389010; A10BB09; 244-260-5; G4PX8C4HKV; S1702; MFCD00409893; 1-(3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl)-3-(4-methylphenyl)sulfonylurea; Gliclazidum [INN-Latin]; Gliclazida [INN-Spanish]; 1-[3-Azabicyclo[3.3.0]oct-3-yl]-3-p-toluenesulfonylurea; N-((hexahydrocyclopenta[c]pyrrol-2(1H)-yl)carbamoyl)-4-methylbenzenesulfonamide; N-(hexahydrocyclopenta[c]pyrrol-2(1H)-ylcarbamoyl)-4-methylbenzenesulfonamide; Benzenesulfonamide,N-[[(hexahydrocyclopenta[c]pyrrol-2(1H)-yl)amino]carbonyl]-4-methyl-; S1702;SE1702; N-[[(Hexahydrocyclopenta[c]pyrrol-2(1H)-yl)amino]carbonyl]-4-methylbenzenesulfonamide; N-(4-Methylbenzenesulfonyl)-N'-(3-azabicyclo(3.3.0)oct-3-yl)urea; Gliclazide?; Glimicron (TN); SMR000542971; SR-01000816184; 1-(3-Azabicyclo[3.3.0]oct-3-yl)-3-p-tolylsulphonylurea; Unava; Diabrezide;; Glyclazide;; Diamicron;; Glimicron;; Nordialex;; Gliclazide CRS; NCGC00016751-01; Prestwick_869; CAS-21187-98-4; Gliclazide (Standard); Gliclazide (Diamicron); Spectrum_001478; SpecPlus_000870; Prestwick0_000558; Prestwick1_000558; Prestwick2_000558; Prestwick3_000558; Spectrum3_001862; Spectrum4_000598; Spectrum5_000753; Gliclazide (JP18/INN); SCHEMBL16387; BSPBio_000635; BSPBio_003304; KBioGR_001096; KBioSS_001958; MLS001215197; MLS001304077; MLS001304118; DivK1c_006966; Gliclazide, powder, >=98%; SPECTRUM1504145; SPECTRUM1505013; SPBio_002556; BPBio1_000699; CHEMBL427216; orb1225682; orb1308313; orb3139692; Urea, 1-(hexahydrocyclopenta[c]pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)-; HY-B0753R; KBio1_001910; KBio2_001958; KBio2_004526; KBio2_007094; KBio3_002806; Gliclazide (S1702; Diamicron); HMS1569P17; HMS1922D15; HMS2090K16; HMS2096P17; HMS2855P09; HMS3656C22; HMS3713P17; HMS3744O13; HMS5081J09; Pharmakon1600-01504145; HY-B0753; MSK10066; Tox21_110590; 1-(4-methylbenzenesulfonyl)-3-{octahydrocyclopenta[c]pyrrol-2-yl}urea; BBL012275; BDBM50103512; EBC-80093; NSC758673; NSC813216; s2601; SBB066074; STK803142; AKOS003237903; AKOS016340698; Tox21_110590_1; AB05958; CCG-213918; DB01120; FG23666; KS-1067; NSC-813216; 1-(3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl)-3-(p-tolylsulfonyl)urea; N-[(hexahydrocyclopenta[c]pyrrol-2(1H)-ylamino)carbonyl]-4-methylbenzenesulfonamide; NCGC00095107-01; NCGC00095107-02; NCGC00095107-03; NCGC00095107-04; NCGC00095107-05; NCGC00095107-06; NCGC00095107-09; NCGC00095107-10; AC-12045; ST076805; SBI-0052662.P002; AB00053165; G0381; G4532; NS00002064; SW196994-3; D01599; D83168; AB00053165-09; AB00053165_10; AB00053165_11; EN300-7359575; F811940; Q290001; SR-01000816184-2; SR-01000816184-3; SR-01000816184-4; BRD-A61154809-001-04-3; BRD-A61154809-001-14-2; BRD-A61154809-001-15-9; BRD-A61154809-001-16-7; Gliclazide, British Pharmacopoeia (BP) Reference Standard; Gliclazide, European Pharmacopoeia (EP) Reference Standard; [(3-azabicyclo[3.3.0]oct-3-yl)amino]-N-[(4-methylphenyl)sulfonyl]carboxamide; N-(3-azabicyclo[3.3.0]oct-3-yl){[(4-methylphenyl)sulfonyl]amino}carboxamide; N-[(Hexahydrocyclopenta[c]pyrrol-2(1H)-yl)carbamoyl]-4-methylbenzene-1-sulfonamide; N-[[(H exahydrocylopenta[c]pyrrol-2(1H)-yl]amino]carbonyl ]-4-methylbenzenesulfonamide; BENZENESULFONAMIDE, N-[[(HEXAHYDROCYCLOPENTA[C]PYRROL-2(1H)-YL)AMINO]CARBONYL]-4-METHYL동의어